One important implication of this hypothesis is that to produce the greatest therapeutic effect on cancer, re-instating or inducing prolonged activation of specific PKC isoforms would ideally occur without subsequent degradation or downregulation of the protein11,12. Here, PRRT2 is linked to cancer.